Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Change in Receivables (2023 - 2025)

CervoMed (CRVO) has disclosed Change in Receivables for 4 consecutive years, with -$934394.0 as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 146.95% to -$934394.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.8 million through Dec 2025, down 236.48% year-over-year, with the annual reading at -$1.8 million for FY2025, 236.48% down from the prior year.
  • Change in Receivables hit -$934394.0 in Q4 2025 for CervoMed, up from -$999588.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $2.0 million in Q4 2024 to a low of -$999588.0 in Q3 2025.
  • Historically, Change in Receivables has averaged $53374.1 across 3 years, with a median of -$180428.0 in 2024.
  • Biggest five-year swings in Change in Receivables: skyrocketed 117.4% in 2024 and later plummeted 478.42% in 2025.
  • Year by year, Change in Receivables stood at $915404.0 in 2023, then surged by 117.4% to $2.0 million in 2024, then plummeted by 146.95% to -$934394.0 in 2025.
  • Business Quant data shows Change in Receivables for CRVO at -$934394.0 in Q4 2025, -$999588.0 in Q3 2025, and $731748.0 in Q2 2025.